InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Conway Charles, Directeur Scientifique. Officer active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. Aggregated, 3 filings have been recorded. Activity tracked since 23 November 2021. The latest transaction was filed on 3 October 2022 (Disposition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Charles Conway is the Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Biohaven.